Synlett 2012; 23(20): 2972-2974
DOI: 10.1055/s-0032-1317687
letter
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Hydroxamic Acids by Using the Acid Labile O-2-Methylprenyl Protecting Group

Anna Nikitjuka, Aigars Jirgensons*
  • Latvian Institute of Organic Synthesis, Riga, 1006, Latvia   Fax: +371(754)1408   Email: aigars@osi.lv
Further Information

Publication History

Received: 01 October 2012

Accepted after revision: 02 November 2012

Publication Date:
28 November 2012 (eFirst)

Abstract

Coupling of carboxylic acids with O-2-methylprenyl hydroxylamine provided O-protected hydroxamic acids, which could be deprotected by treatment with trifluoroacetic acid (TFA) in dichloromethane giving volatile by-products. Protected hydroxamic acids could be N-arylated or alkylated followed by deprotection to give N-substituted hydroxamic acids.

Supporting Information

 
  • References


    • For reviews see:
    • 1a Marmion CJ, Griffith D, Nolan KB. Eur. J. Inorg. Chem. 2004; 3003
    • 1b Rao BG. Curr. Pharm. Des. 2005; 11: 295
    • 1c For a recent application, see: Di Fiore A, Maresca A, Supuran CT, De Simone G. Chem. Commun. 2012; 48: 8838

      For selected references, see:
    • 2a Masaki M, Ohtake J, Sugiyama M, Ohta M. Bull. Chem. Soc. Jpn. 1965; 38: 1802
    • 2b Jung M, Brosch G, Kolle D, Scherf H, Gerhauser C, Loidl P. J. Med. Chem. 1999; 42: 4669
    • 2c Kottirsch G, Feifel R, Neumann U. J. Med. Chem. 2002; 45: 2289
  • 3 Nikam SS, Komberg BE, Johnson DR, Doherty AM. Tetrahedron Lett. 1995; 36: 197
  • 4 Barlaam B, Hamon A, Maudet M. Tetrahedron Lett. 1998; 39: 7865
  • 5 Hou J, Li Z, Fang Q, Feng C, Zhang H, Guo W, Wang H, Gu G, Tian Y, Liu P, Liu R, Lin J, Shi Y.-K, Yin Z, Shen J, Wang PG. J. Med. Chem. 2012; 55: 3066

    • For selected references, see:
    • 6a Yang S.-M, Lagu B, Wilson LJ. J. Org. Chem. 2007; 72: 8123
    • 6b Zhu Z, Mazzola R, Sinning L, McKittrick B, Niu X, Lundell D, Sun J, Orth P, Madison V, Guo Z, Ingram R, Beyer BM. J. Med. Chem. 2008; 51: 725
    • 6c Mwakwari SC, Guerrant W, Patil V, Khan SI, Tekwani BL, Gurard-Levin ZA, Mrksich M, Oyelere AK. J. Med. Chem. 2010; 53: 6100
    • 7a Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S. Bioorg. Med. Chem. Lett. 2001; 11: 2907
    • 7b Grolla AA, Podesta V, Chini MG, Di Micco S, Vallario A, Genazzani AA, Canonico PL, Bifulco G, Tron GC, Sorba G, Pirali T. J. Med. Chem. 2009; 52: 2776
    • 8a Ngu K, Patel DV. J. Org. Chem. 1997; 62: 7088
    • 8b Lai M.-J, Huang H.-L, Pan S.-L, Liu Y.-M, Peng C.-Y, Lee H.-Y, Yeh T.-K, Huang P.-H, Teng C.-M, Chen C.-S, Chuang H.-Y, Liou J.-P. J. Med. Chem. 2012; 55: 3777
  • 9 Moffat D, Patel S, Day F, Belfield A, Donald A, Rowlands M, Wibawa J, Brotherton D, Stimson L, Clark V, Owen J, Bawden L, Box G, Bone E, Mortenson P, Hardcastle A, van Meurs S, Eccles S, Raynaud F, Aherne W. J. Med. Chem. 2010; 53: 8663
  • 10 Mayr H, Foerner W, Schleyer v. R P.. J. Am. Chem. Soc. 1979; 101: 6032
  • 11 Clennan EL, Chen X. J. Am. Chem. Soc. 1989; 111: 5787
  • 12 Typical procedure for deprotection: To a solution of O-protected hydroxamic acid 5i (33 mg, 0.13 mmol) in CH2Cl2 (2.6 mL) and triethylsilane (0.26 mL), was added TFA (0.26 mL) in one portion at r.t. The resulting mixture was stirred at r.t. for 90 min. Solvents were evaporated and the reaction mixture was treated several times with Et2O and evaporated. The residue was dried in vacuo overnight to give hydroxamic acid 6i in quantitative yield as colorless crystals. For characterization of compound 6i, see: Usachova N, Leitis G, Jirgensons A, Kalvins I. Synth. Commun. 2010; 40: 927
  • 13 Haslanger MF, Karanewsky DS. US4604407 A1, 1986 ; Chem Abstr. 105: 208613.
  • 14 Kukosha T, Trufilkina N, Belyakov S, Katkevics M. Synthesis 2012; 44: 2413